The impact of treatment delay on skin cancer in COVID-19 era: a case-control study
Open Access
- 24 December 2021
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 19 (1) , 1-7
Abstract
Background: The outbreak of COVID-19 pandemic led to a 2-month lockdown in Europe. Elective surgeries, including skin cancer excisions, were postponed. The purpose of this prospective case-control study was to assess the impact of the treatment delay on patients with non-melanoma skin cancer (NMSC) or melanoma operated in the first post-lockdown period. Methods: A comparative study of skin cancer operations performed in a 4-month period either in 2020 or in 2019 was conducted. All data were collected from a prospectively maintained clinic database and the pathological reports. Continuous variables were compared with t test or Mann-Whitney U test according to their distribution. Categorical variables were compared with Fisher exact test. Odds ratio (OR) with 95% confidence interval (95% CI) was used to assess the risk of excising high-risk NMSC in 2020 compared with 2019. Results: Skin cancer excision was performed in 158 cases in 2020 compared to 125 cases in 2019 (26.4% increase). Significantly, more SCC were excised in 2020 (p = 0.024). No significant difference for several clinical parameters regarding BCC, SCC, and melanoma was identified. However, the reconstructive method applied, following NMSC excision, was significantly different, requiring frequently either skin grafting or a flap. Conclusion: These results indicate that skin cancer treatment delay, due to COVID-19 pandemic, is related to an increased incidence of SCC and more complicated methods of reconstruction. Considering the relapsing COVID-19 waves, significant skin cancer treatment delays should be avoided. Trial registration: The study adhered to the STROBE statement for case-control studies.Keywords
This publication has 26 references indexed in Scilit:
- To a New NormalAnnals of Surgery, 2020
- Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation)International Journal of Surgery, 2020
- Evaluating Postoperative Outcomes of Patients Undergoing Elective Procedures in an Ambulatory Surgery Center During the COVID-19 PandemicAesthetic Surgery Journal, 2020
- Management of primary skin cancer during a pandemic: Multidisciplinary recommendationsCancer, 2020
- Restarting Essential Surgery in the Era of COVID-19Annals of Surgery, 2020
- Managing COVID-19 in Surgical SystemsAnnals of Surgery, 2020
- Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plansBritish Journal of Surgery, 2020
- Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- COVID-19 Outbreak and Surgical PracticeAnnals of Surgery, 2020
- The COVID-19 Pandemic and Plastic Surgery: Literature Review, Ethical Analysis, and Proposed GuidelinesPlastic and Reconstructive Surgery, 2020